Products
The simultaneous detection of three markers (cTnI / CK-MB / myo) can diagnose patients with myocardial infarction more sensitively, specifically and quickly, so as to early diagnose and treat the patients, and reduce risk of missed diagnosis.
Intended Use
This cTnI/CK-MB/MYO Test Kit (Time Resolved Fluorescence Immunochromatographic Assay) is suitable for quantitative detection of cardiac troponin I, creatine kinase isoenzyme and myoglobin in human serum/plasma /whole blood in vitro.
For Medical Professional Use Only!
Product Information
|
Production name |
Test samples |
Specifications |
|
cTnI/CK-MB/MYO Quantitative Test Kit (TRFIA) |
serum/plasma/whole blood |
20T/Kit, 50T/Kit |
Storage Conditions and Expiry Date
The unopened kit was stored in 2℃~8℃ for 18 months. The product can be stored at temperature (20℃~30℃) for 30 days if expiry printed on the package is not exceeded. The temperature change during transportation (<37℃) has no effect on product quality. The reagent strip and the sample buffer are used in one-to-one mode, that is, a reagent strip is matched with a sample buffer to detect a blood sample.After unsealing, it can be stabilized for 1 hour at room temperature. Under normal humidity and light conditions, store and use according to the above requirements.
Product Performance
Accuracy: the relative deviation from the target value should be within 15%.
Limit of detection:cTnI ≤0.05 ng/ml, CK-MB≤0.5 ng/ml,MYO≤20 ng/ml.
Linearity range: The regression coefficient(r≥0.9900) should be detected in samples(cTnI:[0.1~20]ng/ml, CK-MB:[1~50] ng/ml, MYO: [25~300] ng/ml).
Repeatability: coefficient of variation（CV）is no more than 15%.
Inter-batch difference: coefficient of variation between batches（CV）is no more than 15%
底部版权信息
Copyright©2021 Lumigenex (Suzhou) Co., Ltd. All Rights Reserved. Website construction: www.300.cn